Latest filing published 10 Sept 2026 for BFB Health Ltd., €5.7M.
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This profile gathers the share dealings of Wu Mansheng in BFB Health Ltd., where the filings describe the role as chief executive. In total, 5 filings cover trades dated from 28 November 2025 to 7 September 2026.
The open-market record is one-sided, with 4 purchases worth €9.3M and not one sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. 2026 to date brings 4 purchases and no sales.
The median purchase comes to €1.7M. Measured against the company's value, the median purchase equals 1.9% of market capitalisation, across 4 purchases where it is known. Across 4 purchases, this insider has always bought alone, with no colleague buying within 30 days.
The newest entry dates from 10 September 2026: an open-market purchase of €5.7M, in BFB Health Ltd. Typically, a trade is published a median of 7 days after it takes place. This delay matters because a trade only becomes useful information once it is public. This summary is built from HKEX disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 of 5 declarations